```html

Uroschesis (Urine Retention) – A Complete Medical Guide

Overview

Uroschesis, commonly called urinary retention, is the inability to completely empty the bladder. It can be acute (a sudden inability to urinate) or chronic (gradual bladder emptying problems that develop over weeks to months). Retention may be partial (some urine remains) or complete (no urine passes).

It affects both men and women, but the epidemiology differs:

• In men, especially those >50 years, urinary retention is often linked to prostate enlargement. The Mayo Clinic estimates that up to 30 % of men over 70 experience some form of retention.
• In women, retention is less common but can follow surgery, neurological disease, or medication use. A systematic review found an overall prevalence of 5–10 % in older women.
• Overall, acute urinary retention accounts for about 1–2 % of emergency department visits in the United States each year (CDC).

Because urine is normally sterile, prolonged retention can lead to infection, bladder damage, and kidney injury, making timely recognition essential.

Symptoms

Symptoms vary with acute versus chronic retention and may differ by gender.

• Inability to start urinating despite a strong urge (acute).
• Weak, hesitating, or intermittent stream – the flow may stop and start.
• Feeling of incomplete emptying after voiding (common in chronic).
• Frequent urge to urinate but passing only small amounts (post‑void dribbling).
• Lower abdominal distention or a palpable “bladder‑full” feeling.
• Pain or discomfort in the suprapubic region (more typical of acute retention).
• Urinary leakage or dribbling after attempting to void.
• Cloudy or foul‑smelling urine – may indicate a secondary infection.
• Fever, chills, flank pain – signs of a progressing infection or upper‑tract involvement.
• Nighttime awakenings to urinate (nocturia), especially in chronic cases.

Causes and Risk Factors

Urinary retention is multifactorial. The underlying cause is usually either obstructive (blocking urine flow) or neurogenic (impairing bladder muscle control).

Obstructive Causes

• Benign prostatic hyperplasia (BPH) – enlarged prostate compresses the urethra (most common in men).
• Prostate cancer or post‑prostate‑surgery scarring.
• Urethral stricture – scar tissue narrowing the urethra.
• Pelvic organ prolapse in women (cystocele).
• Bladder stones or tumors that mechanically block the outlet.
• Severe constipation or fecal impaction compressing the bladder neck.

Neurogenic Causes

• Spinal cord injury or spinal stenosis.
• Multiple sclerosis, Parkinson’s disease, stroke, or peripheral neuropathy.
• Pelvic surgery (e.g., hysterectomy, radical prostatectomy) that damages nerves.
• Diabetic autonomic neuropathy.

Medication‑Related Causes

• Anticholinergics (e.g., oxybutynin, diphenhydramine) – reduce bladder contractility.
• Alpha‑adrenergic agonists (e.g., pseudoephedrine) – tighten urethral smooth muscle.
• Opioids and certain anesthetics (especially spinal or epidural).
• Antidepressants (tricyclics) and antihistamines.

Other Risk Factors

• Age > 50 years (both sexes).
• Male gender (obstruction by prostate).
• History of urinary tract infections (UTIs) or prior catheter use.
• Chronic neurological disease.
• Pelvic radiation therapy.
• Trauma to the pelvic region.

Diagnosis

Diagnosing uroschesis begins with a thorough history and physical examination, followed by targeted tests to identify cause and severity.

Clinical Evaluation

• History: onset, duration, voiding pattern, medications, surgeries, neurologic symptoms.
• Physical exam: abdomen for bladder distention, digital rectal exam (men) to assess prostate size, pelvic exam (women) for prolapse or masses.

Key Diagnostic Tests

1. Post‑void residual (PVR) volume – measured by bladder ultrasound or catheterization. A PVR > 150 mL suggests significant retention (Cleveland Clinic).
2. Urinalysis & urine culture – screens for infection.
3. Uroflowmetry – assesses urine flow rate; low peak flow (< 10 mL/s) often indicates obstruction.
4. Urodynamic studies – detailed pressure‑flow testing for complex neurogenic cases.
5. Imaging:
   • Renal & bladder ultrasound – detects hydronephrosis, bladder wall thickening.
   • CT or MRI of pelvis – evaluates masses, stones, or spinal pathology.
6. Cystoscopy – endoscopic visualization of urethra and bladder, used when tumors, strictures, or stones are suspected.

Treatment Options

Treatment is individualized based on the underlying cause, severity, and patient comorbidities. The goals are to relieve obstruction, restore normal voiding, prevent infection, and protect kidney function.

Acute Urinary Retention

1. Immediate bladder decompression:
   • Urethral catheterization (straight or Foley) – first‑line, often resolves symptoms quickly.
   • If catheterization fails, a suprapubic catheter may be placed under ultrasound guidance.
2. Identify and treat precipitating cause (e.g., discontinue offending medication, treat infection with antibiotics).
3. Short‑term alpha‑blockers (e.g., tamsulosin 0.4 mg daily) can ease urethral smooth‑muscle tone in men.
4. Follow‑up within 24–48 hours to assess need for ongoing catheterization.

Chronic Urinary Retention

• Clean Intermittent Catheterization (CIC) – patient‑self catheterization performed several times daily; reduces infection risk compared with indwelling catheters.
• Pharmacologic therapy:
  • Alpha‑blockers (tamsulosin, alfuzosin) for BPH‑related obstruction.
  • 5‑alpha‑reductase inhibitors (finasteride, dutasteride) – shrink prostate over months.
  • Anticholinergics are **avoided** as they may worsen retention; if overactive bladder symptoms coexist, a careful trial of beta‑3 agonist (mirabegron) may be considered.
• Surgical interventions (when medical therapy fails):
  • Transurethral resection of the prostate (TURP) – gold standard for BPH.
  • Holmium laser enucleation of the prostate (HoLEP) – minimally invasive, good for larger prostates.
  • Urethral dilation or internal urethrotomy for strictures.
  • Pelvic organ prolapse repair in women.
  • Neuromodulation or sacral nerve stimulation for refractory neurogenic retention.

Lifestyle & Supportive Measures

• Timed voiding (every 2–3 hours) to train bladder.
• Fluid management – adequate intake (≈2 L/day) but avoid large volumes before bedtime.
• Pelvic floor muscle training (especially for women).
• Limit caffeine, alcohol, and carbonated drinks that irritate the bladder.

Living with Uroschesis (urine retention)

Managing chronic retention is a day‑to‑day challenge that involves both practical strategies and emotional support.

Practical Tips

1. Maintain a bladder diary – record void times, volume, and any incontinence episodes; helps clinicians fine‑tune therapy.
2. Learn proper catheter technique if using intermittent self‑catheterization; follow sterile or clean technique guidelines from your provider.
3. Watch for signs of infection – fever, cloudy urine, new pain; seek prompt care.
4. Use a night‑time alarm or bedside commode if nocturia is disruptive.
5. Stay active – walking improves bowel regularity, reducing pressure on the bladder.

Emotional & Social Considerations

• Discuss concerns with a urologist or continence nurse; many clinics offer support groups.
• Consider counseling if anxiety or embarrassment about catheter use interferes with daily life.
• Inform close family members or caregivers about your catheter schedule to avoid misunderstandings.

Prevention

While some causes (e.g., prostate enlargement) are age‑related, several modifiable measures can lower the risk of developing urinary retention:

• Regular medical check‑ups for men over 50, including prostate exams.
• Control chronic diseases: tight blood‑sugar control in diabetes, blood pressure management, and weight maintenance.
• Avoid or limit medications that impair bladder contractility; discuss alternatives with your physician.
• Stay hydrated but avoid excessive fluids in a short period.
• Manage constipation with dietary fiber, adequate fluid, and, if needed, stool softeners.
• Practice pelvic floor exercises (Kegels) to maintain muscle tone.
• Promptly treat urinary tract infections to prevent scarring or chronic dysfunction.

Complications

If urinary retention is left untreated, several serious complications can develop:

• Urinary tract infection (UTI) – retained urine provides a breeding ground for bacteria.
• Acute or chronic pyelonephritis – infection ascends to kidneys, potentially causing renal scarring.
• Hydronephrosis – swelling of kidneys due to back‑pressure, detectable on ultrasound.
• Bladder stones – precipitated by stagnant urine.
• Reduced bladder compliance – over‑distended bladder loses elasticity, leading to overflow incontinence.
• Renal insufficiency or failure – prolonged high pressure can impair glomerular filtration.
• Psychological distress – anxiety, depression, and reduced quality of life.

When to Seek Emergency Care

---

Sources: Mayo Clinic, CDC, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Cleveland Clinic, WHO, peer‑reviewed articles from The Journal of Urology and Neurourology and Urodynamics.

```